Chiropractors in Murrells Inlet, SC Accepting Medicare

25 Chiropractors found. Showing 21 - 25

Deangelo Chiropractic Chiropractor Medicare: Medicare Enrolled Practice Location: 5182 Horry Dr, Unit A, Murrells Inlet, SC 29576 Phone: 843-651-8787    Fax: 843-651-8788

Murrells Inlet Chiropractic Chiropractor Medicare: Medicare Enrolled Practice Location: 3334 S Highway 17, Murrells Inlet, SC 29576 Phone: 843-633-1179    Fax: 843-655-3460

Dr. Justin Edward Cataldo, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 658 Wachesaw Rd, Murrells Inlet, SC 29576 Phone: 843-357-9617    Fax: 843-357-9639

Mr. William J. Hauck, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 9408 Highway 17 Byp, Suite 2, Murrells Inlet, SC 29576 Phone: 843-215-6635    Fax: 843-215-6637

Grand Strand Health And Wellness, Llc Chiropractor Medicare: Medicare Enrolled Practice Location: 3959 Highway 17, Suite C, Murrells Inlet, SC 29576 Phone: 843-357-9355    Fax: 843-357-9350

News Archive

Onyx Pharmaceuticals to present data on carfilzomib and ONX 0803 at the 51st ASH Annual Meeting

Onyx Pharmaceuticals, Inc. today announced nearly 20 presentations evaluating carfilzomib and ONX 0803 (SB 1518) in hematological cancers at the 51st American Society of Hematology (ASH) Annual Meeting December 5-8, 2009 in New Orleans, LA. Among the data presentations are four oral and seven poster presentations highlighting data from the carfilzomib development program in patients with relapsed and refractory multiple myeloma.

Positive Phase 3 results from Tarsa's ORACAL study validates Unigene's oral peptide drug delivery technology

Unigene Laboratories, Inc. a leader in the design, delivery, manufacture and development of peptide-based therapeutics announced today that the statistically significant top-line results released by its licensee, Tarsa Therapeutics, validate its proprietary oral peptide drug delivery technology.

First study to show SCAT2 as useful sideline tool for concussion

Princeton's Margot Putukian, MD presented "Prospective Clinical Assessment (SCAT2), Hybrid Neuropsychological Testing and Neuroimaging in the Evaluation of Sports-Related Concussions" at the 21st American Medical Society for Sports Medicine Annual Meeting in Atlanta, Ga. on April 24, 2012.

New therapy for osteoporosis provides protection against bone fractures in postmenopausal women

A recent analysis of results from a randomized controlled clinical trial indicates that abaloparatide-SC, a novel therapy for osteoporosis, provides consistent protection against bone fractures in postmenopausal women with osteoporosis regardless of their baseline bone density, age, and previous history of fracture.

EntreMed announces issuance of patent for clinical-stage compound, 2-methoxyestradiol

EntreMed, Inc., a clinical-stage pharmaceutical company developing therapeutics for the treatment of a variety of cancers, announced the issuance of a U.S. patent covering methods of treatment and formulations for its clinical-stage compound, 2-methoxyestradiol.

Read more Medical News

› Verified 6 days ago

• 1
• 2(current)